John Overdeck’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

John Overdeck’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,800	Closed	-$227K	–	3656
2018 Q3	$227K	Buy	+1,800	New	+$190K	﹤0.01%	2934
2017 Q3	–	Sell	-19,000	Closed	-$2.3M	–	3308
2017 Q2	$2.3M	Buy	19,000 +17,000	+850%	+$1.97M	0.01%	1323
2017 Q1	$226K	Buy	+2,000	New	+$233K	﹤0.01%	2679
2016 Q4	–	Sell	-7,800	Closed	-$1.28M	–	3607
2016 Q3	$1.28M	Buy	+7,800	New	+$1.23M	﹤0.01%	1785

John Overdeck's ICPT Position: Q4 2023 in Review

John Overdeck sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 84,718 shares — an estimated $1.57M sold.

John Overdeck first reported a position in ICPT in Q4 2013 and held it in 26 quarters. The position peaked at $37.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

John Overdeck reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
John Overdeck sold 84,718 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $1.57M.
John Overdeck first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and held it in 26 quarters.
John Overdeck's Intercept Pharmaceuticals, Inc. position peaked at $37.3M in Q4 2019.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.